These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10339601)
1. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. Mann MJ; Gibbons GH; Hutchinson H; Poston RS; Hoyt EG; Robbins RC; Dzau VJ Proc Natl Acad Sci U S A; 1999 May; 96(11):6411-6. PubMed ID: 10339601 [TBL] [Abstract][Full Text] [Related]
2. Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. Poston RS; Mann MJ; Hoyt EG; Ennen M; Dzau VJ; Robbins RC Transplantation; 1999 Sep; 68(6):825-32. PubMed ID: 10515383 [TBL] [Abstract][Full Text] [Related]
3. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits. Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759 [TBL] [Abstract][Full Text] [Related]
4. Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. Kodama T; Tan PH; Offiah I; Partridge T; Cook T; George AJ; Blomley MJ Ultrasound Med Biol; 2005 Dec; 31(12):1683-91. PubMed ID: 16344130 [TBL] [Abstract][Full Text] [Related]
5. Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts. Feeley BT; Poston RS; Park AK; Ennen MP; Hoyt EG; Vriens PW; Robbins RC Transplantation; 2000 Mar; 69(6):1067-74. PubMed ID: 10762209 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. Poston RS; Ennen M; Pollard J; Hoyt EG; Billingham ME; Robbins RC J Thorac Cardiovasc Surg; 1998 Sep; 116(3):386-96. PubMed ID: 9731779 [TBL] [Abstract][Full Text] [Related]
7. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures. Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586 [TBL] [Abstract][Full Text] [Related]
8. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494 [TBL] [Abstract][Full Text] [Related]
9. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553 [TBL] [Abstract][Full Text] [Related]
11. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model. Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520 [TBL] [Abstract][Full Text] [Related]
12. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740 [TBL] [Abstract][Full Text] [Related]
13. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050 [TBL] [Abstract][Full Text] [Related]
14. A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer. von der Leyen HE; Braun-Dullaeus R; Mann MJ; Zhang L; Niebauer J; Dzau VJ Hum Gene Ther; 1999 Sep; 10(14):2355-64. PubMed ID: 10515455 [TBL] [Abstract][Full Text] [Related]
15. DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes. Mann MJ; Morishita R; Gibbons GH; von der Leyen HE; Dzau VJ Mol Cell Biochem; 1997 Jul; 172(1-2):3-12. PubMed ID: 9278227 [TBL] [Abstract][Full Text] [Related]
16. Development of antisense oligodeoxynucleotides for transplantation. Stepkowski SM Curr Opin Mol Ther; 2000 Jun; 2(3):304-17. PubMed ID: 11249625 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of antisense mechanisms of action. Ghosh C; Stein D; Weller D; Iversen P Methods Enzymol; 2000; 313():135-43. PubMed ID: 10595352 [No Abstract] [Full Text] [Related]